Haemonetics
HAE
$84.08
Share price
-0.67%
Change (1 day)
-2.88%
Change (1 year)
Categories
P/S ratio for Haemonetics (HAE)
P/S ratio as of June 2024 (TTM): 3.40
According to Haemonetics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.39757. At the end of 2023 the company had a P/S ratio of 3.42.
P/S ratio history for Haemonetics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.42 | -3.09% |
| 2022 | 3.52 | 23.95% |
| 2021 | 2.84 | -58.31% |
| 2020 | 6.82 | 17.74% |
| 2019 | 5.79 | 8.1% |
| 2018 | 5.36 | 56.98% |
| 2017 | 3.41 | 48.04% |
| 2016 | 2.31 | 25.75% |
| 2015 | 1.83 | -11.96% |
| 2014 | 2.08 | -9.73% |
| 2013 | 2.31 | -9.32% |
| 2012 | 2.54 | 18.34% |
| 2011 | 2.15 | -7.06% |
| 2010 | 2.31 | 4.99% |
| 2009 | 2.20 | -10.4% |
| 2008 | 2.46 | -24.66% |
| 2007 | 3.26 | 21.62% |
| 2006 | 2.68 | -15.47% |
| 2005 | 3.18 | 29.18% |
| 2004 | 2.46 | 43.56% |
| 2003 | 1.71 | 10.31% |
| 2002 | 1.55 | -44.95% |
| 2001 | 2.82 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.90 | 14.78% | 🇺🇸 USA |
 Medtronic MDT | 3.31 | -2.68% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 5.10 | 50.00% | 🇺🇸 USA |
 Baxter BAX | 1.14 | -66.33% | 🇺🇸 USA |
 Becton Dickinson BDX | 3.32 | -2.16% | 🇺🇸 USA |
 Stryker Corporation SYK | 6.20 | 82.46% | 🇺🇸 USA |
 PerkinElmer
PKI | 4.31 | 26.73% | 🇺🇸 USA |
 Cerus CERS | 2.07 | -39.19% | 🇺🇸 USA |